UBS Asset Management Americas Inc. raised its holdings in Agilent Technologies Inc (NYSE:A) by 0.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 984,490 shares of the medical research company’s stock after acquiring an additional 1,528 shares during the quarter. UBS Asset Management Americas Inc. owned approximately 0.30% of Agilent Technologies worth $65,931,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Dupont Capital Management Corp acquired a new position in Agilent Technologies in the 3rd quarter valued at approximately $101,000. Front Row Advisors LLC acquired a new position in Agilent Technologies in the 4th quarter valued at approximately $106,000. AMG National Trust Bank acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $201,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Agilent Technologies during the third quarter worth $213,000. Finally, Cannell Peter B & Co. Inc. acquired a new stake in shares of Agilent Technologies during the third quarter worth $215,000.
In other Agilent Technologies news, VP Mark Doak sold 4,154 shares of the firm’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total value of $278,318.00. Following the transaction, the vice president now directly owns 68,270 shares of the company’s stock, valued at $4,574,090. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Didier Hirsch sold 20,000 shares of the firm’s stock in a transaction on Monday, November 27th. The shares were sold at an average price of $69.40, for a total transaction of $1,388,000.00. Following the completion of the transaction, the chief financial officer now directly owns 204,851 shares in the company, valued at $14,216,659.40. The disclosure for this sale can be found here. Over the last three months, insiders have sold 154,707 shares of company stock worth $10,944,828.
Several research firms have recently weighed in on A. Robert W. Baird reiterated a “buy” rating and set a $76.00 price objective on shares of Agilent Technologies in a research report on Thursday, January 18th. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Barclays increased their price objective on shares of Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 21st. Deutsche Bank set a $75.00 price objective on shares of Agilent Technologies and gave the stock a “buy” rating in a research report on Tuesday, November 21st. Finally, Cowen reiterated a “hold” rating and set a $70.00 price objective on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Five investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $70.98.
Agilent Technologies Inc (A) opened at $70.70 on Friday. The stock has a market cap of $22,809.66, a price-to-earnings ratio of 119.83, a P/E/G ratio of 2.37 and a beta of 1.28. Agilent Technologies Inc has a 12 month low of $50.86 and a 12 month high of $75.00. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.78 and a current ratio of 3.23.
Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.58 by $0.08. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.16 billion. Agilent Technologies had a net margin of 4.25% and a return on equity of 17.70%. During the same period in the prior year, the firm earned $0.53 earnings per share. analysts predict that Agilent Technologies Inc will post 2.67 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/24/ubs-asset-management-americas-inc-acquires-1528-shares-of-agilent-technologies-inc-a.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.